| 1 | Study | 2.86% | |
| 2 | Liver | 2.86% | |
| 3 | Risk | 2.86% | |
| 4 | Vaccine | 2.86% | |
| 5 | Over | 2.86% | |
| 6 | Cross-Sectional | 2.86% | |
| 7 | Fatty | 2.86% | |
| 8 | Disease | 2.86% | |
| 9 | Gallstones | 1.43% | |
| 10 | Sweeter | 1.43% | |
| 11 | Hazard | 1.43% | |
| 12 | Guidelines | 1.43% | |
| 13 | Are | 1.43% | |
| 14 | Prevalence | 1.43% | |
| 15 | Nutritious | 1.43% | |
| 16 | Breakfast | 1.43% | |
| 17 | Patients | 1.43% | |
| 18 | Getting | 1.43% | |
| 19 | Confirmed | 1.43% | |
| 20 | Sparking | 1.43% | |
| 21 | Shingles | 1.43% | |
| 22 | Frequency | 1.43% | |
| 23 | Alters | 1.43% | |
| 24 | Years | 1.43% | |
| 25 | Distribution | 1.43% | |
| 26 | Asthma | 1.43% | |
| 27 | Among | 1.43% | |
| 28 | Concerns | 1.43% | |
| 29 | COVID-19 | 1.43% | |
| 30 | Government | 1.43% | |
| 31 | Lower | 1.43% | |
| 32 | Adverse | 1.43% | |
| 33 | Trust | 1.43% | |
| 34 | Iraq | 1.43% | |
| 35 | Population | 1.43% | |
| 36 | Bleeding | 1.43% | |
| 37 | Non-alcoholic | 1.43% | |
| 38 | Public | 1.43% | |
| 39 | Analysis | 1.43% | |
| 40 | System | 1.43% | |
| 41 | Factors | 1.43% | |
| 42 | FDA | 1.43% | |
| 43 | Linked | 1.43% | |
| 44 | Rivaroxaban-Associat | 1.43% | |
| 45 | Rhabdomyolysis | 1.43% | |
| 46 | Pakistan | 1.43% | |
| 47 | Statin-Associated | 1.43% | |
| 48 | Event | 1.43% | |
| 49 | Causal | 1.43% | |
| 50 | Eight | 1.43% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||